Match!

Defining and Expanding the Phenotype of QARS-associated Developmental Epileptic Encephalopathy

Published on Dec 1, 2019in Neurology Genetics
· DOI :10.1212/NXG.0000000000000373
Katrine M. Johannesen10
Estimated H-index: 10
,
Diana Mitter (University of Southern Denmark)+ 35 AuthorsRikke S. Møller36
Estimated H-index: 36
Abstract
Objective The study is aimed at widening the clinical and genetic spectrum and at assessing genotype-phenotype associations in QARS encephalopathy. Methods Through diagnostic gene panel screening in an epilepsy cohort, and recruiting through GeneMatcher and our international network, we collected 10 patients with biallelic QARS variants. In addition, we collected data on 12 patients described in the literature to further delineate the associated phenotype in a total cohort of 22 patients. Computer modeling was used to assess changes on protein folding. Results Biallelic pathogenic variants in QARS cause a triad of progressive microcephaly, moderate to severe developmental delay, and early-onset epilepsy. Microcephaly was present at birth in 65%, and in all patients at follow-up. Moderate (14%) or severe (73%) developmental delay was characteristic, with no achievement of sitting (85%), walking (86%), or talking (90%). Additional features included irritability (91%), hypertonia/spasticity (75%), hypotonia (83%), stereotypic movements (75%), and short stature (56%). Seventy-nine percent had pharmacoresistant epilepsy with mainly neonatal onset. Characteristic cranial MRI findings include early-onset progressive atrophy of cerebral cortex (89%) and cerebellum (61%), enlargement of ventricles (95%), and age-dependent delayed myelination (88%). A small subset of patients displayed a less severe phenotype. Conclusions These data revealed first genotype-phenotype associations and may serve for improved interpretation of new QARS variants and well-founded genetic counseling.
  • References (25)
  • Citations (0)
📖 Papers frequently viewed together
1 Citations
20 Citations
22 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References25
Newest
#1Jennifer FriedmanH-Index: 21
#2Desirée E.C. SmithH-Index: 19
Last. Joseph G. GleesonH-Index: 72
view all 29 authors...
Aminoacyl-tRNA synthetases (ARSs) function to transfer amino acids to cognate tRNA molecules, which are required for protein translation. To date, biallelic mutations in 31 ARS genes are known to cause recessive, early-onset severe multi-organ diseases. VARS encodes the only known valine cytoplasmic-localized aminoacyl-tRNA synthetase. Here, we report seven patients from five unrelated families with five different biallelic missense variants in VARS. Subjects present with a range of global devel...
1 CitationsSource
#1Aleksandra Siekierska (Katholieke Universiteit Leuven)H-Index: 7
#2Hannah Stamberger (University of Antwerp)H-Index: 7
Last. Peter De Jonghe (University of Antwerp)H-Index: 79
view all 38 authors...
Aminoacyl tRNA synthetases (ARSs) link specific amino acids with their cognate transfer RNAs in a critical early step of protein translation. Mutations in ARSs have emerged as a cause of recessive, often complex neurological disease traits. Here we report an allelic series consisting of seven novel and two previously reported biallelic variants in valyl-tRNA synthetase (VARS) in ten patients with a developmental encephalopathy with microcephaly, often associated with early-onset epilepsy. In sil...
3 CitationsSource
#1Sabine A. Fuchs (UU: Utrecht University)H-Index: 10
#2Imre F. Schene (UU: Utrecht University)H-Index: 2
Last. Peter M. van Hasselt (UU: Utrecht University)H-Index: 21
view all 16 authors...
Pathogenic variations in genes encoding aminoacyl-tRNA synthetases (ARSs) are increasingly associated with human disease. Clinical features of autosomal recessive ARS deficiencies appear very diverse and without apparent logic. We searched for common clinical patterns to improve disease recognition, insight into pathophysiology, and clinical care. Symptoms were analyzed in all patients with recessive ARS deficiencies reported in literature, supplemented with unreported patients evaluated in our ...
2 CitationsSource
#1Gareth BaynamH-Index: 25
#2Stephanie Broley (Government of Western Australia)H-Index: 4
Last. Jack Goldblatt (UWA: University of Western Australia)H-Index: 45
view all 43 authors...
Background New approaches are required to address the needs of complex undiagnosed diseases patients. These approaches include clinical genomic diagnostic pipelines, utilizing intra- and multi-disciplinary platforms, as well as specialty-specific genomic clinics. Both are advancing diagnostic rates. However, complementary cross-disciplinary approaches are also critical to address those patients with multisystem disorders who traverse the bounds of multiple specialties and remain undiagnosed desp...
8 CitationsSource
#1Esther Leshinsky-Silver (TAU: Tel Aviv University)H-Index: 23
#2Jiqiang Ling (University of Texas Health Science Center at Houston)H-Index: 21
Last. Dorit Lev (TAU: Tel Aviv University)H-Index: 40
view all 9 authors...
Glutaminyl tRNA synthase is highly expressed in the developing fetal human brain. Mutations in the glutaminyl-tRNA synthetase (QARS) gene have been reported in patients with progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. We have previously reported a new recessive syndrome of severe linear growth retardation, poor weight gain, microcephaly, characteristic facial features, cutaneous syndactyly of the toes, high myopia, and intellectual disability in two sisters o...
1 CitationsSource
#1Keith NykampH-Index: 6
#2Michael AndersonH-Index: 87
Last. Scott TopperH-Index: 8
view all 11 authors...
The 2015 American College of Medical Genetics and Genomics–Association for Molecular Pathology (ACMG–AMP) guidelines were a major step toward establishing a common framework for variant classification. In practice, however, several aspects of the guidelines lack specificity, are subject to varied interpretations, or fail to capture relevant aspects of clinical molecular genetics. A simple implementation of the guidelines in their current form is insufficient for consistent and comprehensive vari...
75 CitationsSource
#1M.A. AlabdullatifH-Index: 1
#2M.A. Al DhaibaniH-Index: 1
Last. Ayman W. El-HattabH-Index: 22
view all 4 authors...
Chromosomal microarray (CMA) has significantly improved diagnosing copy number variations (CNVs). Single nucleotide polymorphism (SNP) arrays confer additional utility in detecting regions of homozygosity (ROH). Investigating ROH for genes associated with recessive disorders for follow-up sequencing can aid in diagnosis. In this study, we performed a retrospective review of clinical and molecular data for 227 individuals from a highly consanguineous population who previously had a CMA. Pathogeni...
16 CitationsSource
#1Robert S. Fisher (Stanford University)H-Index: 60
#2Jh Cross (ICH: UCL Institute of Child Health)H-Index: 46
Last. Sameer M. Zuberi (Glas.: University of Glasgow)H-Index: 37
view all 12 authors...
The International League Against Epilepsy (ILAE) presents a revised operational classification of seizure types. The purpose of such a revision is to recognize that some seizure types can have either a focal or generalized onset, to allow classification when the onset is unobserved, to include some missing seizure types, and to adopt more transparent names. Because current knowledge is insufficient to form a scientifically based classification, the 2017 Classification is operational (practical) ...
414 CitationsSource
#1Ingrid E. Scheffer (University of Melbourne)H-Index: 92
#2Samuel F. Berkovic (University of Melbourne)H-Index: 116
Last. Sameer M. Zuberi (Glas.: University of Glasgow)H-Index: 37
view all 16 authors...
Summary The International League Against Epilepsy (ILAE) Classification of the Epilepsies has been updated to reflect our gain in understanding of the epilepsies and their underlying mechanisms following the major scientific advances that have taken place since the last ratified classification in 1989. As a critical tool for the practicing clinician, epilepsy classification must be relevant and dynamic to changes in thinking, yet robust and translatable to all areas of the globe. Its primary pur...
572 CitationsSource
#1Anita Datta (UBC: University of British Columbia)H-Index: 4
#2Alex Lazaridis Ferguson (UBC: University of British Columbia)H-Index: 1
Last. Ramona Salvarinova (UBC: University of British Columbia)H-Index: 6
view all 8 authors...
Glutaminyl-tRNA synthetase (QARS) deficiency has been described to be a cause of a neurodegenerative disorder associated with severe developmental delay, microcephaly, delayed myelination, and intr...
1 CitationsSource
Cited By0
Newest